MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$100.90
+0.27%Leverage
- Debt / equity
- -72.97x
- Net debt / equity
- -41.24x
- Debt / assets
- 0.73x
- Debt / EBITDA
- -0.98x
- Net debt / EBITDA
- -0.55x
Liquidity & coverage
- Current ratio
- 2.86x
- Quick ratio
- 2.74x
- Cash ratio
- 1.97x
- Interest coverage
- -8.01x
- EBITDA / interest
- -57.81x
- Working capital
- $413.5M
Cash & dividend
- FCF / debt
- -0.60x
- Cash flow / debt
- -0.60x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026